Literature DB >> 17216369

Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil.

Eutília A M Freire1, Inês O Maia, Jamile C A Nepomuceno, Rozana M Ciconelli.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mainly young women. During the disease course, many organs and systems can suffer non-reversible damage that decreases both the patient's life span and also their quality of life. To determine the chronic damage and its correlation with quality of life, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was used in 63 patients who met the ACR criteria for SLE. Quality of life (QOL) was measured through the Medical Outcomes Survey short form 36 (SF-36), sociodemographic data were assessed using specific questionnaires, and disease activity was measured by the systemic lupus erythematosus disease activity index. Overall, 32% of the patients presented damage. Neuropsychiatric (25%) and vascular (20%) involvement were the most frequently related. Organic damages were associated with disease duration (p < 0.03). General health status and social aspects of quality of life were also associated with disease duration (p < 0.05 and p < 0.038, respectively). Socioeconomic status and disease activity were not associated with organic damages and quality of life. This study concluded that disease activity, cumulative damage, and quality of life had some influence in the overall view of lupus but those parameters are distinct domains of health status in SLE. Our analysis identified that disease duration had an important association with damage index and general health status.

Entities:  

Mesh:

Year:  2007        PMID: 17216369     DOI: 10.1007/s10067-006-0517-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 2.  Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group.

Authors:  D Gladman; M Urowitz; P Fortin; D Isenberg; C Goldsmith; C Gordon; M Petri
Journal:  J Rheumatol       Date:  1996-11       Impact factor: 4.666

3.  Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life.

Authors:  D D Gladman; M B Urowitz; A Ong; J Gough; A MacKinnon
Journal:  Clin Exp Rheumatol       Date:  1996 May-Jun       Impact factor: 4.473

4.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

Review 5.  Systemic lupus erythematosus VIII: Prognosis.

Authors:  M C Hochberg
Journal:  Md State Med J       Date:  1984-02

6.  Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.

Authors:  T Stoll; C Gordon; B Seifert; K Richardson; J Malik; P A Bacon; D A Isenberg
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

7.  A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE).

Authors:  D D Gladman; M B Urowitz; A Ong; J Gough; A MacKinnon
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

8.  Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen.

Authors:  M C Hochberg; C A Dorsch; E J Feinglass; M B Stevens
Journal:  Arthritis Rheum       Date:  1981-01

Review 9.  Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus.

Authors:  D D Gladman
Journal:  Curr Opin Rheumatol       Date:  1994-09       Impact factor: 5.006

Review 10.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03
View more
  8 in total

1.  BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus.

Authors:  Li-Wei Zhu; Tao Zhang; Hai-Feng Pan; Xiang-Pei Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2010-05-02       Impact factor: 2.980

2.  Patient-Reported Outcomes Predict Mortality in Lupus.

Authors:  Desiree R Azizoddin; Meenakshi Jolly; Shilpa Arora; Ed Yelin; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-13       Impact factor: 4.794

3.  Prevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia.

Authors:  Mislav Cerovec; Branimir Anić; Ivan Padjen; Nada Cikes
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

4.  Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations.

Authors:  Lilianna Kulczycka; Anna Sysa-Jedrzejowska; Ewa Robak
Journal:  Clin Rheumatol       Date:  2010-06-09       Impact factor: 2.980

5.  Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus.

Authors:  Zahra Sayed Bonakdar; Negin Mohtasham; Mansoor Karimifar
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

6.  Damage index in childhood-onset systemic lupus erythematosus in Egypt.

Authors:  Samia Salah; Hala M Lotfy; Abir N Mokbel; Ahmed M Kaddah; Nouran Fahmy
Journal:  Pediatr Rheumatol Online J       Date:  2011-12-09       Impact factor: 3.054

7.  Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis.

Authors:  Tingrui Wang; Hong Wang; Lijuan Qiu; Lingling Wu; Huayun Ling; Yu Xue; Ying Zhou; Huijuan Chen; Dong-Qing Ye; Bin Wang
Journal:  J Immunol Res       Date:  2022-04-16       Impact factor: 4.493

8.  Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus.

Authors:  Mathilda Björk; Örjan Dahlström; Jonas Wetterö; Christopher Sjöwall
Journal:  BMC Musculoskelet Disord       Date:  2015-08-12       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.